Table 1 Participant characteristics
From: DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA
Group | APOE4 noncarriers (n = 13) | APOE4 carriers (n = 9) | p Value |
|---|---|---|---|
Female/male sex | 8/5 | 2/7 | 0.07 |
White/nonwhite race | 8/5 | 4/5 | 0.93 |
Age, years | 37.1 (15.7) | 32.1 (10.7) | 0.39 |
Weight, kg | 77.1 (15.7) | 85.7 (20.4) | 0.30 |
BMI, kg/m2 | 26.2 (4.2) | 27.1 (5.0) | 0.64 |
Systolic blood pressure, mmHg | 111 (9.2) | 118.4 (14.7) | 0.35 |
Diastolic blood pressure, mmHg | 60.3 (10.6) | 62.8 (7.2) | 0.61 |
Fasting glucose, mg/dl | 94 (9.3) | 90 (9.5) | 0.37 |
Total cholesterol, mg/dl | 162 (42.9) | 168.1 (31.1) | 0.70 |
HDL-C, mg/dl | 49.8 (17.7) | 53.7 (11.9) | 0.54 |
LDL-C, mg/dl | 98.3 (33.4) | 101 (28.8) | 0.84 |
Estimated DHA intake based on DHQ, mg/day | 40 (41) | 130 (120) | 0.1 |
Brain volume, ml | 1246 (150) | 1232 (62) | 0.76 |
Plasma APOE levels, ÎĽg/ml | 15.8 (5.7) | 10.7 (6.1) | 0.06 |